Improved in vitro renal tubular drug transport modelling to meet regulatory and development cost challenges - Newcells

Retinal platform

An in vitro, light responsive, retinal model for accurate predictions of in vivo outcomes you can have confidence in.

aProximateTM

Kidney platform

The most advanced near-physiological high throughput kidney proximal tubule cells (PTC) model to investigate drug transport modalities in vitro.

Lung epithelia model

Lung model

A model to investigate airway physiology, viral infection, drug safety and environmental impacts on lung airway epithelia.

Sinusoid iPSC-derived Liver model

Liver model

We are developing a model of liver sinusoid derived from human induced pluripotent stem cells (iPSC).

Published 14th December 2020 | News

Improved in vitro renal tubular drug transport modelling to meet regulatory and development cost challenges

The proximal tubule is key due to its role in the excretion and reabsorption of many xenobiotic compounds. Due to the high costs associated with drug discovery and the clinical demand for effective drugs, in vitro human cell-based kidney models using renal proximal tubule epithelia are becoming popular tools for early-stage testing.

Director of ADMET technology, Dr Colin Brown, has written an article for the latest version European Pharmaceutical Review. In this article he describes why it is important that in vitro models of renal drug transport are physiologically representative of the human kidney and their importance in modelling nephrotoxicity and drug-to-drug interactions (DDI) and predicting drug-induced kidney injury (DIKI) in the later stages of drug development and trial.

 

Read the full article here.

Share This:
Tweet Post Share